Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Nuvectis Pharma (NVCT) Return on Assets (2022 - 2026)

Nuvectis Pharma has reported Return on Assets over the past 5 years, most recently at 0.01% for Q1 2026.

  • Quarterly results put Return on Assets at 0.01% for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Mar 2026 was 0.01% (changed 0.0% YoY), and the annual figure for FY2025 was 0.01%, changed 0.0%.
  • Return on Assets reached 0.01% in Q1 2026 per NVCT's latest filing, down from 0.01% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.01% in Q3 2022 and bottomed at 0.01% in Q1 2022.
  • Median Return on Assets over the past 5 years was 0.01% (2026), compared with a mean of 0.01%.
  • Peak annual rise in Return on Assets hit 0bps in 2023, while the deepest fall reached 0bps in 2023.
  • Over 5 years, Return on Assets stood at 0.01% in 2022, then dropped by -27bps to 0.01% in 2023, then increased by 1bps to 0.01% in 2024, then increased by 26bps to 0.01% in 2025, then fell by -21bps to 0.01% in 2026.
  • Business Quant data shows Return on Assets for NVCT at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.